Xiaotao Wang
About Xiaotao Wang
Xiaotao Wang is the Biomarker Lead for China R&D at Bristol Myers Squibb in Shanghai, China. He has extensive experience in biochemistry and molecular biology, having held various leadership roles in prominent pharmaceutical companies.
Current Title and Role
Xiaotao Wang serves as the Biomarker Lead, China R&D at Bristol Myers Squibb, based in Shanghai, China. In this prominent role, Wang is responsible for leading biomarker research initiatives, contributing to critical developments in the R&D department.
Previous Positions
Before his current role, Xiaotao Wang has held several significant positions at top pharmaceutical companies. He was an Associate Director of Biomarker Research at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2018 to 2021. Prior to that, he was the Director of Preclinical R&D at Simcere Pharmaceutical Group for five months in 2017-2018. He also served as the Associate Director and Head of NCE Molecular Discovery at GSK, China from 2016 to 2018, and as a Senior Scientist/Team Leader in Assay and Screening at AstraZeneca from 2012 to 2016 in Shanghai.
Early Career
Xiaotao Wang's early career includes notable roles in academia and industry. He worked as an Associate Director of Quantitative Biology at Crown Bioscience, Inc. in 2011 and as a Senior Research Fellow at Duke-NUS Graduate Medical School from 2010 to 2011 in Singapore. Additionally, he held postdoctoral positions at University College Dublin and the Genome Institute of Singapore. His extensive experience started at the China State Institute of Pharmaceutical Industry, where he served as an Associate Professor from 1991 to 2006.
Educational Background
Xiaotao Wang obtained his Ph.D. in Biochemistry and Molecular Biology from The University of Hong Kong, studying from 2001 to 2005. He also earned a Master of Philosophy (M.Phil.) from the same institution between 1997 and 2000. He holds a Bachelor of Science (B.Sc.) in Biochemistry from Fudan University, which he completed in 1991.
Skills and Expertise
Xiaotao Wang has considerable expertise in multiple assay development platforms, including biochemical, biophysical, and cell-based HTS. His specialization encompasses enzymology, protein-protein interaction, protein-ligand binding, and mechanism of action studies. Wang also has a strong background in protein expression, purification, characterization, folding, and understanding structure-function relationships. His project management capabilities and effective communication and management skills further complement his technical proficiencies.